India’s global source for priority medicines, GNH India

23 January 2018

India’s global source for priority medicines, GNH India - a pharmaceutical company, is well known for providing the most comprehensive global medicinal supply in the marketplace. With over 14 years of expertise, the company is committed to excellence by providing high-quality products, at competitive prices, with fast and reliable service, while remaining true to the core values of accountability, ethical business practices, and innovation. GNH India is an independent and professionally run full-line pharma wholesaler who ships over 1, 35,000 product lines to more than 180 countries worldwide. This will be the sixth year of GNH India participating in Arab Health festival 2018, which is a hub of opportunities for pharma experts. GNH India believes that Arab Health-2018 is not only an opportunity to get a hold on the pharma market in Africa, Middle East and Central Asia but is also a platform where companies exchange their ideas in global village of the industry.

Recent developments –

• GNH India is amongst handful of Indian companies which can conduct a trade of orphan drugs with UK Pharmaceutical Company
• While, most established pharma companies avoid trade with Yemen, due to the implication of US Sanctions, GNH India has successfully exported one of the largest orders for anti-malarial pharmaceuticals
• GNH India has successfully imported a life-saving medicine called Olaratumab (trade name Lartruvo) in India
• GNH India, global Indian pharmaceutical distributor, has become the first company in India to clear the Kenyan Pharmacy and Poisons Board audit.
• GNH India hassuccessfully delivered a not for profit consignment of 8 basic medicines to the conflict zone of Somalia.